Browse 14 Life Science companies funded by General Catalyst. See funding amounts, founder contacts, and investment details.
Chai Discovery develops artificial intelligence models and software for protein engineering and molecular design.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Ossium Health builds a bone marrow bank to treat blood cancers.
Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.
Lila Sciences creates a scientific superintelligence platform and autonomous labs for life sciences, chemistry, and materials science.
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
OASYS NOW is a medtech start-up that uses AI to optimize clinical trial recruitment, advancing precision medicine accessibility.
CTRL Therapeutics operates a biotechnology company that researches cell therapy and treatment.
Truvian Sciences develops an automated benchtop system to provide lab-accurate blood testing results.
Kernel is a neuroscience company that specializes in developing brain-recording technologies.
TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
View all companies funded by General Catalyst across every industry and funding stage.
View Full General Catalyst Portfolio